SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-018656
Filing Date
2019-05-13
Accepted
2019-05-10 19:43:31
Documents
57
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arct-10q_20190331.htm 10-Q 1088463
2 EX-31.1 arct-ex311_11.htm EX-31.1 19806
3 EX-31.2 arct-ex312_12.htm EX-31.2 19760
4 EX-32.1 arct-ex321_14.htm EX-32.1 9428
5 EX-32.2 arct-ex322_13.htm EX-32.2 9413
  Complete submission text file 0001564590-19-018656.txt   4452154

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arct-20190331.xml EX-101.INS 797241
7 XBRL TAXONOMY EXTENSION SCHEMA arct-20190331.xsd EX-101.SCH 45128
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arct-20190331_cal.xml EX-101.CAL 40193
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arct-20190331_def.xml EX-101.DEF 146602
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arct-20190331_lab.xml EX-101.LAB 352004
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arct-20190331_pre.xml EX-101.PRE 268138
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-900-2660
Arcturus Therapeutics Ltd. (Filer) CIK: 0001566049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35932 | Film No.: 19816531
SIC: 2834 Pharmaceutical Preparations